Skip to main content

Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.

Author(s): Rubanova, Yulia; Shi, Ruian; Harrigan, Caitlin F; Li, Roujia; Wintersinger, Jeff; et al

Download
To refer to this page use: http://arks.princeton.edu/ark:/88435/pr1r53f
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRubanova, Yulia-
dc.contributor.authorShi, Ruian-
dc.contributor.authorHarrigan, Caitlin F-
dc.contributor.authorLi, Roujia-
dc.contributor.authorWintersinger, Jeff-
dc.contributor.authorSahin, Nil-
dc.contributor.authorDeshwar, Amit-
dc.contributor.authorPCAWG Evolution and Heterogeneity Working Group-
dc.contributor.authorMorris, Quaid-
dc.contributor.authorPCAWG Consortium-
dc.date.accessioned2021-10-08T19:46:56Z-
dc.date.available2021-10-08T19:46:56Z-
dc.date.issued2020-02-05en_US
dc.identifier.citationRubanova, Yulia, Shi, Ruian, Harrigan, Caitlin F, Li, Roujia, Wintersinger, Jeff, Sahin, Nil, Deshwar, Amit, PCAWG Evolution and Heterogeneity Working Group, Morris, Quaid, PCAWG Consortium. (2020). Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.. Nature communications, 11 (1), 731 - ?. doi:10.1038/s41467-020-14352-7en_US
dc.identifier.issn2041-1723-
dc.identifier.urihttp://arks.princeton.edu/ark:/88435/pr1r53f-
dc.description.abstractThe type and genomic context of cancer mutations depend on their causes. These causes have been characterized using signatures that represent mutation types that co-occur in the same tumours. However, it remains unclear how mutation processes change during cancer evolution due to the lack of reliable methods to reconstruct evolutionary trajectories of mutational signature activity. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole-genome sequencing data from 2658 cancers across 38 tumour types, we present TrackSig, a new method that reconstructs these trajectories using optimal, joint segmentation and deconvolution of mutation type and allele frequencies from a single tumour sample. In simulations, we find TrackSig has a 3-5% activity reconstruction error, and 12% false detection rate. It outperforms an aggressive baseline in situations with branching evolution, CNA gain, and neutral mutations. Applied to data from 2658 tumours and 38 cancer types, TrackSig permits pan-cancer insight into evolutionary changes in mutational processes.en_US
dc.format.extent731 - ?en_US
dc.languageengen_US
dc.language.isoen_USen_US
dc.relation.ispartofNature communicationsen_US
dc.rightsFinal published version. This is an open access article.en_US
dc.titleReconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.en_US
dc.typeJournal Articleen_US
dc.identifier.doidoi:10.1038/s41467-020-14352-7-
dc.identifier.eissn2041-1723-
pu.type.symplectichttp://www.symplectic.co.uk/publications/atom-terms/1.0/journal-articleen_US

Files in This Item:
File Description SizeFormat 
TrajectoriesMutationSignatureActivitiesCancerTrackSig.pdf4.1 MBAdobe PDFView/Download


Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.